FDA Media Alert Detail

Drug Shortage

FDA Drug Shortage: Rivastigmine Film, Extended Release

  • U.S. Food and Drug Administration
  • September 18, 2026
  • ID: shortage-rivastigmine-film-extended-release-mylan-pharmaceuticals-inc-a-viatris-company-0378-9070-93

Drug Shortage Details

Generic NameRivastigmine Film, Extended Release
Manufacturer / CompanyMylan Pharmaceuticals Inc., a Viatris Company
Therapeutic CategoryNeurology
Availability StatusShortage
Status (FDA list)To Be Discontinued
NDC Package Code0378-9070-93
Presentation & Dosage Form

Rivastigmine, Film, Extended Release, 4.6 mg/24 h (NDC 0378-9070-93)

Manufacturer Contact Info

800-796-9526

Content syndicated from the U.S. Food and Drug Administration (FDA) Drug Shortages Database.
View Official Announcement on FDA.gov

Recent FDA Updates

FDA Safety Alert
Sodium Chloride Flush Recall: Spectra Medical Removes Sodium...
Sep 18, 2026
FDA Safety Alert
Nitric Oxide Delivery System Correction: NOxBOX Updates Use...
Sep 18, 2026
Drug Shortage
FDA Drug Shortage: Melphalan Hydrochloride Injection
Sep 16, 2026
Back to FDA Media Center